COMMERCIALIZATION



Nucleic Acid research reagents:


o TransIT® Transfection Reagents

§ reagents of unique lipid and polymer formulations that achieve superior delivery efficiency of pDNA and siRNA with minimal cytotoxic effects

o Label IT® Labeling Reagents

§ employ proprietary chemistry to covalently attach labeling molecules to DNA and RNA.

§ faster and more robust than traditional multi-step enzymatic labeling, and can be used for intracellular tracking, chromosome analysis, and microarray labeling


Therapeutic products:

o MyoDys® Muscular Dystrophy Therapy

§ Stage: Phase I/II in preparation

§ treat disease by inserting a gene encoding active dystrophin into affected muscles to delay or prevent loss of muscle function


o Peripheral Ischemia Therapy

§ Stage: Research

§ treatment is based upon delivery of a gene encoding an angiogenic factor to the affected limb, which induces revascularization of the limb